Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

598
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
598
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

791
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
791
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

767
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
767

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The value of social robots supporting informal care: a discrete choice experiment among informal caregivers.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same author

Stochastic virtual population in type 1 diabetes.

PloS one·2026
Same author

Improving the value of population health data for health policy and decision-making using machine learning algorithms in EQ-5D-5L index estimation.

Scientific reports·2026
Same author

Bioinformatics-Inspired IMU Stride Sequence Modeling for Fatigue Detection Using Spectral-Entropy Features and Hybrid AI in Performance Sports.

Sensors (Basel, Switzerland)·2026
Same author

SR-LLM: An incremental symbolic regression framework driven by LLM-based retrieval-augmented generation.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

The Validation of the Parental Self-Efficacy Scale for Diabetes Management Among Parents of Children Wearing a Continuous Glucose Monitoring Sensor.

Biomedicines·2025

Related Experiment Video

Updated: Dec 29, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

A robust fixed point transformation-based approach for type 1 diabetes control.

Levente Kovács1

  • 1Physiological Controls Research Center, Research and Innovation Center of the Óbuda University, Kiscelli Street 82., Budapest, 1032 Hungary.

Nonlinear Dynamics
|February 7, 2020
PubMed
Summary

This study demonstrates a new nonlinear robust fixed point transformation (RFPT) method for diabetes mellitus (DM) control. The RFPT method effectively manages blood glucose (BG) levels despite model uncertainties and data limitations.

Keywords:
Adaptive controlDiabetes controlRFPTRobust fixed point methodT1DM

More Related Videos

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

916
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.2K

Related Experiment Videos

Last Updated: Dec 29, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K
Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

916
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.2K

Area of Science:

  • Biomedical Engineering
  • Control Systems
  • Endocrinology

Background:

  • Diabetes mellitus (DM) presents significant modeling and control challenges due to nonlinearity, time delays, and intermittent blood glucose (BG) data.
  • Accurate DM models and adaptive control are essential for managing BG levels effectively, especially when internal states are unmeasurable and BG data is not continuous.

Purpose of the Study:

  • To demonstrate the usability of a novel nonlinear robust fixed point transformation (RFPT)-based controller design method for diabetes management.
  • To address the complexities of DM control, including nonlinear dynamics, time delays, and limited BG monitoring.

Main Methods:

  • Utilized a nonlinear robust fixed point transformation (RFPT) controller design, requiring only an approximate model.
  • Incorporated parallel simulated approximate models to provide additional internal system information.
  • Applied the RFPT-based technique to the physiological problem of diabetes mellitus.

Main Results:

  • The RFPT-based controller demonstrated successful handling of unfavorable control effects without requiring simplifications.
  • The method proved effective even with a roughly approximate model of the diabetes mellitus system.
  • The usability of the novel RFPT technique was validated in the context of diabetes physiological control.

Conclusions:

  • The nonlinear RFPT-based control method is a viable approach for managing diabetes mellitus.
  • This technique offers robust control solutions for complex physiological systems with inherent uncertainties and data limitations.
  • The RFPT method provides a promising avenue for advanced diabetes management systems.